-
Cytoreductive surgery (CRS) is a
surgical procedure that aims to
reduce the
amount of
cancer cells in the
abdominal cavity for
patients with
tumors that...
-
surgery (
cytoreductive surgery) for
ovarian cancer under the
premise of
reducing macroscopic disease. In the 60s and 70s this
aggressive cytoreductive approach...
- chemotherapy, IPHC) with
cytoreductive surgery. The
standard of care for
mucinous adenocarcinoma with
clinical condition PMP
involves cytoreductive surgery (CRS)...
-
antiplatelet therapy to
reduce risk of
blood clots, and
additional cytoreductive therapy to
reduce the
number of red
blood cells produced in the bone...
- with
indolent systemic mastocytosis with very
troublesome symptoms,
cytoreductive therapy can be indicated. ɑ-interferon.
Given as
subcutaneous injections...
-
secondary thrombocytosis.
Treatment Low-dose aspirin, plateletpheresis,
cytoreductive therapy.
Prognosis Median survival is 18 years.
Frequency 0.6-2.5/100...
- KH,
Pardanani A,
Butterfield JH, Li CY,
Tefferi A (December 2009). "
Cytoreductive therapy in 108
adults with
systemic mastocytosis:
Outcome analysis and...
- is
called surgical debulking of
tumors is
known as
cytoreduction or
cytoreductive surgery (CRS); "cytoreduction"
refers to
reducing the
number of tumor...
-
known for
developments in
surgical oncology of the abdomen,
including cytoreductive surgery followed by
hyperthermic intraperitoneal chemotherapy, or HIPEC...
- Kim SE, Lee JW, Lee JH, Kim BG, Bae DS (March 2010). "The role of
cytoreductive surgery for non-genital
tract metastatic tumors to the ovaries". European...
